approval
saveSTEQEYMA (USTEKINUMAB-STBA) — FDA approval
community read0 votes
Sponsor: CELLTRION, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvalSTEQEYMA: STEQEYMA (USTEKINUMAB-STBA) — FDA approvalApr 28, 2025
- approvalYUFLYMA: YUFLYMA (ADALIMUMAB-AATY) — FDA approvalMay 21, 2025
- approvalYUFLYMA: YUFLYMA (ADALIMUMAB-AATY) — FDA approvalMay 21, 2025
- approvalYUFLYMA: YUFLYMA (ADALIMUMAB-AATY) — FDA approvalApr 7, 2025
- approvalSTEQEYMA: STEQEYMA (USTEKINUMAB-STBA) — FDA approvalJun 13, 2025
- approvalomalizumab biosimilar: OMLYCLO (OMALIZUMAB-IGEC) — FDA approvalMar 7, 2025
comments(0)
5-min edit window · permanent after that